Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major

Fitness of Leishmania donovani Parasites Resistant to Drug Combinations

(2015) Raquel García-Hernández et al.   PLoS Neglected Tropical Diseases

Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania

(2014) Gisele A. B. Canuto et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

In VitroScreening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein

(2014) Paola Vacchina et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum

(2014) S. Hendrickx et al.   PARASITOLOGY RESEARCH

LmaPA2G4, a Homolog of Human Ebp1, Is an Essential Gene and Inhibits Cell Proliferation in L. major

(2014) Brianna Norris-Mullins et al.   PLoS Neglected Tropical Diseases

Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism

(2013) Isabel M. Vincent et al.   International Journal for Parasitology-Drugs and Drug Resistance

Drug-resistant microorganisms with a higher fitness – can medicines boost pathogens?

(2012) Manu Vanaerschot et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

(2012) T. P. C. Dorlo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Leishmaniasis: Current status of available drugs and new potential drug targets

(2012) Nisha Singh et al.   Asian Pacific Journal of Tropical Medicine

Impact of Continuous Axenic Cultivation in Leishmania infantum Virulence

(2012) Diana Moreira et al.   PLoS Neglected Tropical Diseases

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol

(2012) Sarah Hendrickx et al.   PLoS Neglected Tropical Diseases

Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania major Population as Determined by Whole Genome Sequencing

(2012) Adriano C. Coelho et al.   PLoS Neglected Tropical Diseases

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

(2012) Vasundhra Bhandari et al.   PLoS Neglected Tropical Diseases

In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani

(2011) K. Seifert et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes

(2011) Fernanda de Aquino Marinho et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines

(2011) M. OUAKAD et al.   PARASITOLOGY

Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden

(2011) Manu Vanaerschot et al.   PLoS One

Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage

(2009) Miguel A. Morales et al.   EUKARYOTIC CELL

Fitness costs of resistance to antimalarial drugs

(2008) Ingrid Felger et al.   TRENDS IN PARASITOLOGY